Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,666
-2.99%
|
$816,634
$49.73 P/Share
|
|
Oct 14
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+5.6%
|
$66,664
$4.09 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
6,000
-11.62%
|
$300,000
$50.17 P/Share
|
|
Oct 11
2024
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+10.41%
|
$216,000
$36.57 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.18%
|
$500,000
$50.3 P/Share
|
|
Oct 11
2024
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.41%
|
$20,000
$2.68 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-9.09%
|
$1,500,000
$50.36 P/Share
|
|
Oct 11
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.33%
|
$120,000
$4.09 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
50,000
-27.42%
|
$2,500,000
$50.34 P/Share
|
|
Oct 11
2024
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.5%
|
$200,000
$4.09 P/Share
|
|
Oct 08
2024
|
Barbara Weber |
SELL
Open market or private sale
|
Direct |
5,200
-28.47%
|
$249,600
$48.02 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-1.62%
|
$450,000
$45.13 P/Share
|
|
Oct 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.12%
|
$40,000
$4.09 P/Share
|
|
Sep 16
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,454
-3.09%
|
$63,976
$44.19 P/Share
|
|
Sep 16
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
4,665
-1.73%
|
$205,260
$44.19 P/Share
|
|
Sep 16
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,331
-3.17%
|
$190,564
$44.19 P/Share
|
|
Sep 16
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
11,715
-3.76%
|
$515,460
$44.19 P/Share
|
|
Sep 16
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,244
-2.22%
|
$98,736
$44.19 P/Share
|
|
Sep 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-2.96%
|
$716,681
$43.2 P/Share
|
|
Sep 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Aug 21
2024
|
Barbara Weber |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,808
-9.01%
|
$79,552
$44.83 P/Share
|
|
Aug 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-5.83%
|
$700,014
$42.98 P/Share
|
|
Aug 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Aug 05
2024
|
Frank Clyburn |
BUY
Grant, award, or other acquisition
|
Direct |
6,932
+50.0%
|
-
|
|
Aug 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-1.56%
|
$460,000
$46.04 P/Share
|
|
Aug 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.01%
|
$40,000
$4.09 P/Share
|
|
Jul 15
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-1.19%
|
$766,682
$46.02 P/Share
|
|
Jul 15
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-16.43%
|
$450,000
$45.01 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
25,000
-7.42%
|
$1,125,000
$45.05 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.91%
|
$100,000
$4.09 P/Share
|
|
Jul 09
2024
|
Sushil Patel |
SELL
Open market or private sale
|
Direct |
2,155
-9.75%
|
$94,820
$44.0 P/Share
|
|
Jul 09
2024
|
Sushil Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,155
+8.88%
|
$34,480
$16.8 P/Share
|
|
Jul 09
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,399
-4.85%
|
$95,960
$40.83 P/Share
|
|
Jun 26
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,000
-3.88%
|
$76,000
$38.47 P/Share
|
|
Jun 25
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,467
-5.77%
|
$642,213
$39.06 P/Share
|
|
Jun 25
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,467
+5.45%
|
$65,868
$4.09 P/Share
|
|
Jun 24
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
200
-0.07%
|
$7,800
$39.0 P/Share
|
|
Jun 24
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.07%
|
$800
$4.09 P/Share
|
|
Jun 20
2024
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.88%
|
-
|
|
Jun 20
2024
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+17.63%
|
-
|
|
Jun 20
2024
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.88%
|
-
|
|
Jun 20
2024
|
Lorence H. Kim |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+6.37%
|
-
|
|
Jun 20
2024
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+0.21%
|
-
|
|
Jun 20
2024
|
Sushil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+18.97%
|
-
|
|
Jun 20
2024
|
Sandra Horning |
BUY
Grant, award, or other acquisition
|
Direct |
4,800
+4.8%
|
-
|
|
Jun 17
2024
|
Lin Wei Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,589
-7.31%
|
$206,793
$37.39 P/Share
|
|
Jun 17
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,757
-3.3%
|
$65,009
$37.39 P/Share
|
|
Jun 17
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
3,349
-1.23%
|
$123,913
$37.39 P/Share
|
|
Jun 17
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,415
-3.13%
|
$163,355
$37.39 P/Share
|